93 results on '"Maruyama Satoru"'
Search Results
2. History and the Recent Trend of Submarine Power Cables
3. Validation of the Japanese version of the Body Image Scale for bladder cancer patients
4. Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor
5. Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias
6. Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study
7. Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma
8. Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching
9. Outcomes of bacillus Calmette–Guérin therapy without a maintenance schedule for high‐risk non‐muscle‐invasive bladder cancer in the second transurethral resection era
10. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
11. MP14-16 EFFICACY OF NIVOLUMAB PLUS IPILIMUMAB IN PRIMARY TUMOR AS FIRST-LINE THERAPY IN THE PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
12. Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN
13. Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
14. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study
15. Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study
16. Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome
17. PD18-02 THE EFFECTIVENESS OF TEMPLATE-BASED REGIONAL LYMPH NODE DISSECTION IN REDUCING LOCOREGIONAL RECURRENCE IN PATIENTS WITH CLINICALLY NODE-NEGATIVE UPPER URINARY TRACT UROTHELIAL CARCINOMA
18. The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer
19. Optimization of Fluid Loading on Programmable Microfluidic Devices for Bio-protocol Execution
20. Particle therapy for prostate cancer: The past, present and future
21. Nephrometry score correlated with tumor proliferative activity inT1 clear cell renal cell carcinoma
22. MP72-12 COMPARISON OF LONG-TERM OUTCOMES BETWEEN RADICAL PROSTATECTOMY AND INTENSITY-MODULATED RADIATION THERAPY FOR HIGH-RISK LOCALIZED PROSTATE CANCER: A SINGLE-CENTER PROPENSITY SCORE-MATCHED ANALYSIS
23. Bladder-preserving therapy using a real-time tumor-tracking radiotherapy system for muscle-invasive bladder cancer.
24. Patient with an iliopsoas muscle abscess associated with decompensated cirrhosis conservatively treated with hyperbaric oxygen therapy: a case report
25. Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection
26. Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
27. MP18-17 OUTCOME OF REGIONAL LYMPH NODE DISSECTION IN PATIENTS WITH CLINICAL NODE-NEGATIVE UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: CHARACTERISTICS OF MICROMETASTASIS
28. MP78-13 OUTCOME OF MAINTENANCE SYSTEMIC CHEMOTHERAPY WITH DRUG-FREE INTERVAL FOR METASTATIC UROTHELIAL CARCINOMA
29. MP78-20 THE MODIFIED GLASGOW PROGNOSTIC SCORE IS A POWERFUL PROGNOSTIC FACTOR IN METASTATIC UROTHELIAL CARCINOMA PATIENTS RECEIVING SECOND-LINE CHEMOTHERAPY
30. The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor
31. Perioperative morbidity and mortality of octogenarians treated by radical cystectomy—a multi-institutional retrospective study in Japan
32. MP71-17 COMPARATIVE STUDY OF ONCOLOGICAL OUTCOMES OF LAPAROSCOPIC AND OPEN RADICAL NEPHROURETERECTOMY FOR PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT UNDERGOING REGIONAL LYMPH NODE DISSECTION
33. MP31-15 A NEW APPROACH TO MEASURING DETRUSOR CONTRACTION PATTERN CHANGE AFTER RADICAL PROSTATECTOMY
34. Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers
35. Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan
36. Radical prostatectomy restores detrusor contraction pattern according to pressure flow parameters
37. Erratum to: Laparoscopic resection of paraaortic/paracaval neurogenic tumors: surgical outcomes and technical tips
38. Laparoscopic resection of paraaortic/paracaval neurogenic tumors: surgical outcomes and technical tips
39. Chronic papillomatous dermatitis around an ileostoma
40. Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma
41. Diagnostic outcome of ureteroscopy in urothelial carcinoma of the upper urinary tract: Incidence of later cancer detection and its risk factors after the first examination
42. Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis
43. MP45-01 HIGH ALDO-KETO REDUCTASE 1C1 EXPRESSION IN METASTATIC BLADDER CANCER CELLS ASSOCIATED WITH INVASIVE POTENTIAL AND DRUG RESISTANCE
44. MP58-18 OUTCOME OF METASTATIC UROTHELIAL CARCINOMA IN GC ERA: PROGNOSTIC FACTORS FROM REAL-WORLD CLINICAL PRACTICE IN JAPAN
45. V11-06 LAPAROSCOPIC RESECTION OF PARAAORTIC OR PARACAVAL NEUROGENIC TUMORS
46. Outcome of Regional Lymphadenectomy in Accordance with Primary Tumor Location on Laparoscopic Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract: A Prospective Study
47. Concurrent occurrence of renal cell carcinoma with rhabdoid features in a married couple: a case report
48. Abstract 3722: The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and crizotinib-resistant MET-driven renal tumor models
49. Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system
50. MP35-12 THE HSP90 INHIBITOR GANETESPIB SYNERGIZES WITH THE MET KINASE INHIBITOR CRIZOTINIB IN BOTH CRIZOTINIB-SENSITIVE AND CRIZOTINIB-RESISTANT MET-DRIVEN RENAL TUMOR MODELS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.